首页 正文

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment

{{output}}
Triple negative breast cancer (TNBC) is the most aggressive breast cancer (BC) and often affects young women. TNBCs are highly heterogeneous and do not benefit from personalized medicine at localized stages. Most TNBC patients undergo neoadjuvant chemotherapy ... ...